Variant report
Variant | nsv827641 |
---|---|
Chromosome Location | chr16:48244064-48244705 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79921801 | chr16:48244070-48244071 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs373329602 | chr16:48244095-48244096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573242633 | chr16:48244104-48244105 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs185327644 | chr16:48244111-48244112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192125317 | chr16:48244135-48244136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531784658 | chr16:48244143-48244144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567848517 | chr16:48244170-48244171 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548555044 | chr16:48244214-48244215 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541360893 | chr16:48244253-48244254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569339941 | chr16:48244275-48244276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568575514 | chr16:48244295-48244296 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183958302 | chr16:48244312-48244313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547990863 | chr16:48244315-48244316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570992675 | chr16:48244319-48244320 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186865559 | chr16:48244345-48244346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs8051016 | chr16:48244376-48244377 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs569969019 | chr16:48244458-48244459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs8051205 | chr16:48244485-48244486 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs563266165 | chr16:48244508-48244509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191502416 | chr16:48244549-48244550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574218173 | chr16:48244642-48244643 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530505375 | chr16:48244694-48244695 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs142824126 | chr16:48244695-48244696 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs375388252 | chr16:48244697-48244698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Wilms tumour | 21544195 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 21364760 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Disease | 22140031 | CNVD |
Non-syndromic sensorineural hearing loss | 22140031 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:48239400-48245800 | Weak transcription | Right Atrium | heart |
2 | chr16:48239600-48250000 | Weak transcription | Pancreas | Pancrea |
3 | chr16:48241000-48245800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr16:48241200-48244400 | Weak transcription | HMEC | breast |
5 | chr16:48241600-48244400 | Weak transcription | HepG2 | liver |
6 | chr16:48241800-48244400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr16:48243800-48246400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
8 | chr16:48244000-48245200 | Enhancers | Liver | Liver |
9 | chr16:48244000-48245800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr16:48244400-48245200 | Enhancers | HepG2 | liver |
11 | chr16:48244400-48245800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr16:48244400-48246000 | Enhancers | HMEC | breast |